相关实验视频

Updated: Jan 8, 2026

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

在宫性头痛管理中探索疼痛表型

Michael Cropes¹, Albojay Deacon², Evan O Nelson³

¹Department of Family Medicine and Community Health, School of Medicine and Public Health, Doctor of Physical Therapy Program, University of Wisconsin-Madison, Madison, WI, USA. cropes@pt.wisc.edu.

Current pain and headache reports

|December 13, 2025

概括

对于宫性头痛 (CGH) 的疼痛表型化可以通过识别 nociceptive 和 nociplastic 疼痛机制来提高治疗精度. 这种方法指导了定制的干预措施,以便在CGH管理中获得更好的患者结果.

科学领域:

神经学神经学
疼痛医学医学疼痛医学
临床研究临床研究

背景情况:

宫性头痛 (CGH) 干预试验显示出多样化的结果,表明不同的潜在疼痛机制.
疼痛表型,根据主要的疼痛机制对患者进行分类,可以实现更有针对性的CGH治疗.

研究的目的:

探索疼痛表型在治疗宫性头痛中的作用.
为CGH疼痛表型和分层治疗提供基于证据的建议.

主要方法:

对CGH疼痛机制和治疗反应的临床证据的系统审查.
在CGH中,分析了支持 nociceptive 和 nociplastic 疼痛分类的研究.
基于鉴定到的疼痛现象型的治疗建议的综合.

主要成果:

确定了两个主要的CGH疼痛机制:感觉性和可感性.
针对每个表型推的具体治疗方法:肌肉松剂和脊柱操纵两者;抗抑郁药物用于nociplastic;注射/消神用于nociceptive;神经调节用于持久的nociplastic.
针对生活方式因素的教育干预措施对诺基普拉斯性CGH有益.

结论:

疼痛表型为宫性头痛更精确的临床管理提供了一种策略.
需要进一步的前性研究来证实表型化对CGH临床结果的影响.

关键词:

疼痛机制疼痛机制疼痛的表型化疼痛的表型化定量性感官测试是一种定量性的感官测试.康复康复康复康复

更多相关视频

$Subcutaneous Trigeminal Nerve Field Stimulation for Refractory Facial Pain$ 09:35

Subcutaneous Trigeminal Nerve Field Stimulation for Refractory Facial Pain

Published on: May 10, 2017

Dynamic Quantitative Sensory Testing to Characterize Central Pain Processing

Dynamic Quantitative Sensory Testing to Characterize Central Pain Processing

Published on: February 16, 2017

相关概念视频

Analgesia and Pain Management

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...